Fosamax Femur Fractures and Osteonecrosis of the Jaw to be Reviewed by FDA in September

Share Article

Ennis & Ennis, P.A. advises all individuals harmed by bisphosphonates that an FDA advisory committee (http://www.fda.gov/AdvisoryCommittees/Calendar/ucm262477.htm) will hold a meeting on September 9, 2011 at 8 AM to discuss the benefits and risks of long term bisphosphonate use for the treatment and prevention of osteoporosis. The drugs that will be reviewed will be Fosamax, Actonel, Boniva and Reclast.

Fosamax Femur Fracture / Fosamax Thigh Bone Break

Fosamax Related Low Energy Femur Fracture

usually over a period of time patients complaints and injuries decline, but with this drug the longer they use the drug the more injuries we are seeing in our practice.

On July 14, 2011 the FDA announced an FDA advisory committee will hold a meeting on September 9, 2011 at 8 AM to discuss the benefits and risks of long term bisphosphonate use for the treatment and prevention of osteoporosis. The drugs that will be reviewed will be Fosamax, Actonel, Boniva and Reclast. The law firm of Ennis & Ennis, P.A. notes this is a necessary step for informing the public of the potential dangers of bisphosphonates.

The meeting is warranted due to the safety concerns of osteonecrosis of the jaw (jawbone death) and atypical femur fractures (unusual broken thigh bone) that may be associated with the long-term use of bisphosphonates. 

"Although the FDA required all manufacturers of oral bisphosphonates to add warnings about the risk of bone fractures in October 2010, it is imperative that the FDA provide clear guidelines to physicians and patients about the long term use of these drugs" stated attorney David Ennis. "Our law firm has been investigating Fosamax side effects since 2004 and the injuries our clients have sustained have been devastating" reported Ennis. "Usually over a period of time patients complaints and injuries decline, but with this drug the longer they use the drug the more injuries we are seeing in our practice. Each year we receive more injury complaint and unfortunately for our clients this meeting has come a little too late."

Attorney Ennis recommends that anyone who has taken Fosamax or other similar drug who has sustained a femur fracture or osteonecrosis of the jaw should fill out a MedWatch Form (https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm) with the FDA prior to the hearing. Attorney Ennis commented "The manufacturers are still in denial and patients and physicians need to do their part and notify the FDA."

Ennis & Ennis is offering free nationwide confidential consultations to all individuals that have used Fosamax by calling toll free at 1-800-856-6405 or going to http://www.ennislaw.com and filing out an online case evaluation form.

Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington D.C. which specializes in mass torts and represents individuals against pharmaceutical companies as well as medical device makers. Ennis & Ennis, P.A. has been representing clients individually since 1986 and has recovered over $100 million in settlements for it's clients.

Ennis & Ennis, P.A. is also investigating cases involving, Accutane, Avandia, Transvaginal Mesh Implants, Paxil, Zoloft, Prozac, Depuy Hip Recall, Zimmer Hip Recall, Depakote, Reglan, SJS/Dilantin, Yaz, Yasmin and Ocella Birth Control Pills.

Remember the law limits the time you can file a claim so don't wait to explore your legal rights by calling toll free 1-800-856-6405 or going to http://www.ennislaw.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Attorney David Ennis
Ennis & Ennis, P.A.
1(800) 856-6405
Email >